BCRX
Price
$8.95
Change
-$0.40 (-4.28%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
1.87B
30 days until earnings call
CLDX
Price
$20.39
Change
+$0.10 (+0.49%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
1.35B
38 days until earnings call
OPK
Price
$1.31
Change
-$0.00 (-0.00%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
920.03M
30 days until earnings call
Interact to see
Advertisement

BCRX or CLDX or OPK

Header iconBCRX vs CLDX vs OPK Comparison
Open Charts BCRX vs CLDX vs OPKBanner chart's image
BioCryst Pharmaceuticals
Price$8.95
Change-$0.40 (-4.28%)
Volume$105.24K
Capitalization1.87B
Celldex Therapeutics
Price$20.39
Change+$0.10 (+0.49%)
Volume$129.31K
Capitalization1.35B
OPKO Health
Price$1.31
Change-$0.00 (-0.00%)
Volume$31.72K
Capitalization920.03M
BCRX vs CLDX vs OPK Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BCRX: $9.35CLDX: $20.29OPK: $1.32)
Brand notoriety: CLDX and OPK are not notable and BCRX is notable
BCRX and CLDX are part of the Biotechnology industry, and OPK is in the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BCRX: 146%, CLDX: 251%, OPK: 238%
Market capitalization -- BCRX: $1.87B, CLDX: $1.35B, OPK: $920.03M
$BCRX [@Biotechnology] is valued at $1.87B. $CLDX’s [@Biotechnology] market capitalization is $ $1.35B. $OPK [@Medical Specialties] has a market capitalization of $ $920.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $ $304.6B to $ $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $ $3.82T to $ $0. The average market capitalization across the [@Biotechnology] industry is $ $2.3B. The average market capitalization across the [@Medical Specialties] industry is $ $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s), and OPK’s FA Score reflects 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • CLDX’s FA Score: 0 green, 5 red.
  • OPK’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than CLDX, which in turn is a better option than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 5 TA indicator(s) are bullish while CLDX’s TA Score has 3 bullish TA indicator(s), and OPK’s TA Score reflects 4 bullish TA indicator(s).

  • BCRX’s TA Score: 5 bullish, 3 bearish.
  • CLDX’s TA Score: 3 bullish, 4 bearish.
  • OPK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than OPK, which in turn is a better option than CLDX.

Price Growth

BCRX (@Biotechnology) experienced а -7.42% price change this week, while CLDX (@Biotechnology) price change was -1.02% , and OPK (@Medical Specialties) price fluctuated +2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.48%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was +2.70%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

CLDX is expected to report earnings on Aug 07, 2025.

OPK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+2.48% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.88B) has a higher market cap than CLDX($1.35B) and OPK($920M). BCRX YTD gains are higher at: 24.344 vs. OPK (-10.204) and CLDX (-19.707). BCRX has higher annual earnings (EBITDA): 47.6M vs. OPK (-65.52M) and CLDX (-213.94M). CLDX has more cash in the bank: 673M vs. BCRX (295M) and OPK (95.9M). CLDX has less debt than OPK and BCRX: CLDX (3.43M) vs OPK (327M) and BCRX (795M). OPK has higher revenues than BCRX and CLDX: OPK (863M) vs BCRX (503M) and CLDX (7.56M).
BCRXCLDXOPK
Capitalization1.88B1.35B920M
EBITDA47.6M-213.94M-65.52M
Gain YTD24.344-19.707-10.204
P/E RatioN/AN/A26.11
Revenue503M7.56M863M
Total Cash295M673M95.9M
Total Debt795M3.43M327M
FUNDAMENTALS RATINGS
BCRX vs CLDX vs OPK: Fundamental Ratings
BCRX
CLDX
OPK
OUTLOOK RATING
1..100
525050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
56
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
7466100
SMR RATING
1..100
1009490
PRICE GROWTH RATING
1..100
466162
P/E GROWTH RATING
1..100
10010098
SEASONALITY SCORE
1..100
508585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (32) in the Biotechnology industry is in the same range as CLDX (56) and is somewhat better than the same rating for OPK (68). This means that BCRX's stock grew similarly to CLDX’s and somewhat faster than OPK’s over the last 12 months.

CLDX's Profit vs Risk Rating (66) in the Biotechnology industry is in the same range as BCRX (74) and is somewhat better than the same rating for OPK (100). This means that CLDX's stock grew similarly to BCRX’s and somewhat faster than OPK’s over the last 12 months.

OPK's SMR Rating (90) in the Biotechnology industry is in the same range as CLDX (94) and is in the same range as BCRX (100). This means that OPK's stock grew similarly to CLDX’s and similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (46) in the Biotechnology industry is in the same range as CLDX (61) and is in the same range as OPK (62). This means that BCRX's stock grew similarly to CLDX’s and similarly to OPK’s over the last 12 months.

OPK's P/E Growth Rating (98) in the Biotechnology industry is in the same range as BCRX (100) and is in the same range as CLDX (100). This means that OPK's stock grew similarly to BCRX’s and similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXCLDXOPK
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 22 days ago
79%
N/A
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
81%
Bearish Trend 18 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFOCX31.850.44
+1.40%
Marsico Focus
JDINX52.110.26
+0.50%
Janus Henderson Overseas N
RTDTX16.050.08
+0.50%
Russell Inv Multifactor US Equity M
RSLAX60.610.19
+0.31%
American Funds SMALLCAP World R1
IEYCX8.380.01
+0.12%
Macquarie Climate Solutions C

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-4.16%
BEAM - CLDX
54%
Loosely correlated
-1.98%
ATXS - CLDX
51%
Loosely correlated
+2.39%
RVMD - CLDX
50%
Loosely correlated
-1.52%
CRNX - CLDX
50%
Loosely correlated
-1.48%
DNLI - CLDX
49%
Loosely correlated
-2.69%
More